<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.874396</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Extrathyroidal Extension Prediction of Papillary Thyroid Cancer With Computed Tomography Based Radiomics Nomogram: A Multicenter Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Pengyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1550302"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Xinxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jingjing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1493381"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mao</surname>
<given-names>Ning</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/513893"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Haicheng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Guibin</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1638202"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Xiao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Luchao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Che</surname>
<given-names>Kaili</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Qinglin</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Guan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mou</surname>
<given-names>Yakui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1539764"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Song</surname>
<given-names>Xicheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1019212"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Big data and Artificial Intelligence Laboratory, Yantai Yuhuangding Hospital, Qingdao University</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Thyroid Surgery, Yantai Yuhuangding Hospital, Qingdao University</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Second Clinical Medicine College, Binzhou Medical University, Yantai</institution>, <addr-line>Shandong</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Paolo Miccoli, University of Pisa, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Clara Ugolini, University of Pisa, Italy; Sabrina Rosaria Paparo, University of Pisa, Italy</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xicheng Song, <email xlink:href="mailto:drxchsong@163.com">drxchsong@163.com</email>; Yakui Mou, <email xlink:href="mailto:muykmd@126.com">muykmd@126.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>874396</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Yu, Wu, Li, Mao, Zhang, Zheng, Han, Dong, Che, Wang, Li, Mou and Song</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Yu, Wu, Li, Mao, Zhang, Zheng, Han, Dong, Che, Wang, Li, Mou and Song</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objectives</title>
<p>To develop and validate a Computed Tomography (CT) based radiomics nomogram for preoperative predicting of extrathyroidal extension (ETE) in papillary thyroid cancer (PTC) patients</p>
</sec>
<sec>
<title>Methods</title>
<p>A total of 153 patients were randomly assigned to training and internal test sets (7:3). 46 patients were recruited to serve as an external test set. A radiologist with 8 years of experience segmented the images. Radiomics features were extracted from each image and Delta-radiomics features were calculated. Features were selected by using one way analysis of variance and the least absolute shrinkage and selection operator in the training set. K-nearest neighbor, logistic regression, decision tree, linear-support vector machine (linear -SVM), gaussian-SVM, and polynomial-SVM were used to build 6 radiomics models. Next, a radiomics signature score (Rad-score) was constructed by using the linear combination of selected features weighted by their corresponding coefficients. Finally, a nomogram was constructed combining the clinical risk factors with Rad-scores. Receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and calibration curve were performed on the three sets to evaluate the nomogram&#x2019;s performance.</p>
</sec>
<sec>
<title>Results</title>
<p>4 radiomics features were selected. The six models showed the certain value of radiomics, with area under the curves (AUCs) from 0.642 to 0.701. The nomogram combining the Rad-score and clinical risk factors (radiologists&#x2019; interpretation) showed good performance (internal test set: AUC 0.750; external test set: AUC 0.797). Calibration curve and DCA demonstrated good performance of the nomogram.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Our radiomics nomogram incorporating the radiomics and radiologists&#x2019; interpretation has utility in the identification of ETE in PTC patients.</p>
</sec>
</abstract>
<kwd-group>
<kwd>papillary thyroid cancer</kwd>
<kwd>extrathyroidal extension (ETE)</kwd>
<kwd>radiomics</kwd>
<kwd>contrast-enhanced CT</kwd>
<kwd>nomogram</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="4"/>
<equation-count count="2"/>
<ref-count count="34"/>
<page-count count="11"/>
<word-count count="4870"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Highlights</title>
<list list-type="bullet">
<list-item>
<p>Radiomics features were extracted from non-contrast and contrast-enhanced CT images, and Delta-radiomics features were calculated.</p>
</list-item>
<list-item>
<p>6 classifiers (KNN, LR, DT, linear-SVM, gaussian-SVM, and polynomial-SVM) were used to construct radiomics models and showed favorable discriminatory abilities.</p>
</list-item>
<list-item>
<p>The nomogram model combining the radiomics and radiologists&#x2019; interpretation showed good predictive performance.</p>
</list-item>
</list>
</sec>
<sec id="s2" sec-type="intro">
<title>Introduction</title>
<p>While thyroid cancer is one of the most common cancers worldwide, it has a very low mortality rate (<xref ref-type="bibr" rid="B1">1</xref>). Papillary thyroid cancer (PTC) is the most common histologic subtype of thyroid cancer (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). In the 8<sup>th</sup> edition of AJCC (American Joint Committee on Cancer) (<xref ref-type="bibr" rid="B4">4</xref>), extrathyroidal extension (ETE), which was subdivided into gross ETE and microscopic ETE, refers to the primary tumor invades the surrounding structures including the strap muscles, trachea, vasculature, larynx, esophagus, and recurrent laryngeal nerve. Furthermore, ETE is an independent risk factor associated with lymph node metastasis and directly affects the clinical outcomes of PTC patients (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). The 15-year survival rate of PTC patients with ETE is significantly lower than that of patients without ETE. Therefore, the diagnosis of ETE is essential for the treatment decision of PTC.</p>
<p>Ultrasound (US), magnetic resonance imaging (MRI), and Computed Tomography (CT) are common non-invasive imaging modality for preoperative ETE diagnosis. US has a high degree of accuracy and sensitivity for identifying ETE (~ 70%), but low specificity (27.2%-68.9%) leads to a high risk of false positive results (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>), and US relying on the experience level of the operator is subjective. MRI is slightly inferior to US but similar to CT with regards to accuracy (<xref ref-type="bibr" rid="B9">9</xref>). Young Lan Seo et&#xa0;al. (<xref ref-type="bibr" rid="B10">10</xref>), found that CT could accurately identify most types of ETE (i.e., esophageal invasion). Furthermore, contrast-enhanced computed tomography (CE-CT) offers an additional phase (venous phase) and three-dimensional images. However, it is difficult to accurately predict ETE based only on traditional images, and obtain the guidance needed for preoperative planning, because interpretation of the images depends on the experience level of the radiologist or surgeon. Besides, histopathological examination, which is the gold standard for diagnosing ETE, is an invasive method, and usually used to verify a preoperative assessment of ETE obtained by using non-invasive tools. Thus, a novel non-invasive tool is needed to help surgeons predict ETE and make clinical decisions prior to performing an operation.</p>
<p>In recent years, Radiomics, the high-throughput extraction of large amounts of image features from radiographic images, can be used to build a mineable high-dimensional database of original material obtained by machine learning (<xref ref-type="bibr" rid="B11">11</xref>). Radiomics can also be used to identify the underlying heterogeneity of images that can be difficult to detect with human eyes. Combined with Machine leaning, radiomics are generally used by researchers to predict the prognosis of patients with tumors and assess the impact of various diseases (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Until now, no study has built a predictive model of ETE using a CT radiomics nomogram adding to time sequential features and then validated the model in a multicenter study. We have achieved that goal.</p>
<p>In this study, we established an effective radiomics nomogram capable of predicting the ETE of PTC based on CT images.</p>
</sec>
<sec id="s3">
<title>Methods</title>
<sec id="s3_1">
<title>Patients</title>
<p>This was a retrospective, multicenter, and diagnostic study. From January 2019 to December 2019, 153 patients, which were collected consecutively from Yantai Yuhuangding Hospital, were randomly assigned to a training set or an internal test set at a ratio of 7:3 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). Additionally, 46 consecutive patients at Qilu Hospital of Shandong University were recruited to serve as an external test set from June 2019 to December 2019 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). The inclusion and exclusion criteria can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Appendices</bold>
</xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flow chart of patients&#x2019; enrolment in <bold>(A)</bold> training, internal test set and <bold>(B)</bold> external test set. <bold>(C)</bold> Flow chart of study work. <bold>(D, E)</bold> Examples of regions of interest (ROIs) segmentation on contrast-enhanced computed tomography (CE-CT) images.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-874396-g001.tif"/>
</fig>
<p>The protocol for this retrospective study was approved by the Institutional Review Board of The Affiliated Yantai Yuhuangding Hospital of Qingdao University. The requirement for obtaining written informed consent from the patients was waived by the review board. A study work flow diagram is shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>.</p>
</sec>
<sec id="s3_2">
<title>Radiologists&#x2019; Interpretation of ETE</title>
<p>CT assessments of ETE were performed by two experienced radiologists, one with 15 years of experience and another with 5 years of experience. Both radiologists were blinded to histopathological results. Any disagreement was resolved by discussion or consultation with a third radiologist who had 20 years of experience. ETE was reported on CT images when at least one of the following CT criteria was fulfilled: 1) tumor in contact with 180&#xb0; or more of the tracheal, esophageal, muscle or vascular circumference; 2) loss of normal structure; 3) a clinical symptom (e.g., ipsilateral vocal cord palsy) was present that could be explained by the CT images; 4) tumor showed poorly defined margin with heterogeneous signal intensity in adjacent soft tissue; 5) focal bulging out or disruption of the thyroid capsule by tumor; 6) more than 25% of perimeter of the tumor was abutting the thyroid capsule (<xref ref-type="bibr" rid="B10">10</xref>). Kendall&#x2019;s coefficient of concordance <italic>W</italic> (Kendall&#x2019;s <italic>W</italic>) was used to evaluate inter-radiologist agreement. <italic>W</italic> scores range between 0 and 1, which was graded as very good (0.80 to 1.00), good (0.60 to 0.80), fair (0.40 to 0.60), moderate (0.20 to 0.40) or poor (&lt;0.20) (<xref ref-type="bibr" rid="B14">14</xref>).</p>
</sec>
<sec id="s3_3">
<title>Image Segmentation</title>
<p>The Image Acquisition protocol is shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Appendices</bold>
</xref>. After that, a radiologist with 8 years of experience manually delineated the PTC regions of interest (ROI) (<xref ref-type="bibr" rid="B15">15</xref>) on non-contrast and venous phase CT images by using an ITK-SNAP (version 3.8.0; <uri xlink:href="http://www.itksnap.org">www.itksnap.org</uri>). Based on their traits, ROIs were manually delineated along the tumor contour on each transverse section and the ROIs in each slice constituted a volume of interest (VOI). A sample of segmentation process is shown in <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D, E</bold>
</xref>. Three months later, another two radiologists segmented the images of 30 patients who were randomly selected to assess the intra- and inter-observer reproducibility of radiomics features by intra- and inter-class correlation coefficients (ICCs). An ICC &gt; 0.8 indicated an excellent agreement of radiomics features.</p>
</sec>
<sec id="s3_4">
<title>Feature Extraction</title>
<p>Before feature extraction, VOIs were prepossessed included gray value standardization, gray level discretization, and image resampling. A total of 2818 radiomics features were originally extracted from each VOI by using PyRadiomics (<xref ref-type="bibr" rid="B16">16</xref>) on Python (version 3.7). A total of 1409 sequential features based on time series were calculated as Delta <sub>(radiomics feature)</sub>, which was defined as the difference between features seen on the venous phase and non-contrast CT images. Delta <sub>(radiomics feature)</sub> was calculated as follows:</p>
<disp-formula>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mtext>Delta</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>radiomics&#xa0;feature</mml:mtext>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>Feature</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>venous&#xa0;phase</mml:mtext>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mtext>Feature</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>non-contrast&#xa0;phase</mml:mtext>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math>
</disp-formula>
<p>A total of 4227 features (containing radiomics features and sequential features) were identified for each patient containing 19 types of first order statistics, 13 types of Shape features, 28 types of Gray-Level Co-occurrence Matrix (GLCM) features, 16 types of Gray-Level Run-Length Matrix (GLRLM) features, 16 types of Gray Level SizeZone Matrix (GLSZM) features, and 56 types of sequential features.</p>
</sec>
<sec id="s3_5">
<title>Features Selection</title>
<p>The values of the extracted features were standardized with z scores by using mean and standard deviation values. Next a two-step procedure for dimensionality reduction and feature selection was devised. First, an analysis of variance (ANOVA) was performed to screen out discriminative features in the training set, with only features having a <italic>P</italic> &lt; 0.05 being selected. Next, the least absolute shrinkage and selection operator (LASSO) method was used to reduce the dimensions of features, identify the most significant features (<xref ref-type="bibr" rid="B17">17</xref>), and make a second selection.</p>
</sec>
<sec id="s3_6">
<title>Radiomics Models Construction and Evaluation</title>
<p>K-Nearest Neighbor (KNN), Logistics Regression (LR), Decision Tree (DT), Linear-support vector machine (Linear-SVM), Gaussian-SVM, and Polynomial-SVM methods were used to construct radiomics models, respectively. Area under the curve (AUC) was regarded as a performance indicator and used to evaluate the performance of the radiomics-based models built by using each classifier. Finally, a radiomics signature (Rad-score) was calculated by using a linear combination of selected features weighted by the corresponding LASSO coefficients.</p>
</sec>
<sec id="s3_7">
<title>Clinical Risk Factors Selection and Nomogram Construction</title>
<p>In the training set, one-way&#xa0;ANOVA and multivariate logistic regression analysis were used to screen clinical risk factors including sex, age, primary site, tumor diameter, and radiologist interpretation to identify the clinical risk factors for ETE. To quantify the roles of the Rad-score and clinical risk factors in predicting ETE, both of those risk factors were included in a multivariate logistic regression analysis that was conducted using a backward-stepwise approach, where collinearity was considered and risk factors with a variance inflation factor (VIF) &gt; 10 and a <italic>P</italic> &gt; 0.05 were excluded. When the minimum Akaike information criterion was reached, the Akaike information was taken as the criterion, the stepwise procedure was stopped, and the final multivariate logistic regression constituted the nomogram.</p>
</sec>
<sec id="s3_8">
<title>Nomogram Validation</title>
<p>The nomogram&#x2019;s predictive performance was evaluated in the training set, internal test set, and external test set, respectively. The nomogram&#x2019;s performance was evaluated in terms of the receiver operating characteristic (ROC) curve. In particular, the comparison between the nomogram and radiologists&#x2019; interpretation was illustrated in the same ROC curve. A decision curve analysis (DCA) was plotted for the entire set and applied in a clinical usefulness evaluation of the nomogram by calculating the net benefits at different threshold values in the training and test sets. In addition, a calibration (agreement between observations and prediction of ETE) curve was used to evaluate the agreement between actual status and ETE probabilities as predicted by the nomogram, accompanied by the Hosmer-Lemeshow test.</p>
</sec>
<sec id="s3_9">
<title>Statistical Analysis</title>
<p>All statistical analyses were performed using Python (version 3.6, <uri xlink:href="https://www.python.org">https://www.python.org</uri>), R software (version 4.0.3, <uri xlink:href="https://www.r-project.org">https://www.r-project.org</uri>), and SPSS (version 26.0, IBM Corp.). Scikit-Learn, a Python library, was used for selecting radiomics features and constructing a radiomics model. The modules of &#x201c;feature-selection,&#x201d; &#x201c;linear-model,&#x201d; &#x201c;svm,&#x201d; &#x201c;neighbors,&#x201d; &#x201c;tree,&#x201d; and &#x201c;metrics&#x201d; were used for the entire procedure. The &#x201c;rms&#x201d; package in R software was used to select clinical risk factors, build the nomogram, and plot calibration curves. The &#x201c;rmda&#x201d; package was used to perform DCA. SPSS software was used to compare categorical variables (i.e., sex, T stage, primary site, radiologists&#x2019; interpretation, and lymph node metastasis) by using the &#x3c7;<sup>2</sup> test or Fisher&#x2019;s exact test. Continuous variables were compared by using the student&#x2019;s t test or Mann-Whitney U test, when appropriate. Statistical significance was two-sided, and a P &lt; 0.05 was considered to be statistically significant.</p>
</sec>
</sec>
<sec id="s4" sec-type="results">
<title>Results</title>
<sec id="s4_1">
<title>Clinical Characteristics</title>
<p>The numbers of enrolled patients in the training set, internal test set, and external test set were 107, 46, and 46, respectively. There were no significant differences in sex, age, diameter, Thyroid Stimulating Hormone (TSH), Free Thyroxine (FT4), Free Triiodothyronine (FT3), and Primary site in each data set, but there was a significant difference in T stage. Details of clinical characteristics in the 3 sets are shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. Radiologist A and radiologist B reported all CT imaging results with good inter-radiologist agreement (Kendall&#x2019;s W, 0.823).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristic of enrolled patients in three sets.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" colspan="2" align="left"/>
<th valign="top" colspan="3" align="center">Training Set (n = 107)</th>
<th valign="top" colspan="3" align="center">Internal Test Set (n = 46)</th>
<th valign="top" colspan="3" align="center">External Test Set (n = 46)</th>
</tr>
<tr>
<th valign="top" align="center">ETE (n  = 28)</th>
<th valign="top" align="center">Non-ETE (n = 79)</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
<th valign="top" align="center">ETE (n = 12)</th>
<th valign="top" align="center">Non-ETE (n = 34)</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
<th valign="top" align="center">ETE (n = 13)</th>
<th valign="top" align="center">Non-ETE (n = 33)</th>
<th valign="top" align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="2" align="left">Sex (M/F)</td>
<td valign="top" align="center">5/23</td>
<td valign="top" align="center">27/52</td>
<td valign="top" align="center">0.105</td>
<td valign="top" align="center">1/11</td>
<td valign="top" align="center">6/28</td>
<td valign="top" align="center">0.440</td>
<td valign="top" align="center">2/11</td>
<td valign="top" align="center">11/22</td>
<td valign="top" align="center">0.223</td>
</tr>
<tr>
<td valign="top" colspan="2" align="left">Age (Years)<sup>a</sup>
</td>
<td valign="top" align="char" char="&#xb1;">44.82 &#xb1; 12.41</td>
<td valign="top" align="char" char="&#xb1;">47.14 &#xb1; 12.07</td>
<td valign="top" align="center">0.388</td>
<td valign="top" align="char" char="&#xb1;">53.42 &#xb1; 13.06</td>
<td valign="top" align="char" char="&#xb1;">48.88 &#xb1; 13.36</td>
<td valign="top" align="center">0.315</td>
<td valign="top" align="center">40.77 &#xb1; 14.66</td>
<td valign="top" align="char" char="&#xb1;">39.39 &#xb1; 12.17</td>
<td valign="top" align="center">0.764</td>
</tr>
<tr>
<td valign="top" colspan="2" align="left">Diameter (mm)<sup>a</sup>
</td>
<td valign="top" align="char" char="&#xb1;">1.53 &#xb1; 0.81</td>
<td valign="top" align="char" char="&#xb1;">1.41 &#xb1; 1.29</td>
<td valign="top" align="center">0.627</td>
<td valign="top" align="char" char="&#xb1;">1.28 &#xb1; 0.65</td>
<td valign="top" align="char" char="&#xb1;">1.86 &#xb1; 1.35</td>
<td valign="top" align="center">0.059</td>
<td valign="top" align="char" char="&#xb1;">1.77 &#xb1; 0.61</td>
<td valign="top" align="char" char="&#xb1;">1.78 &#xb1; 1.12</td>
<td valign="top" align="center">0.962</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="left">Hormone (mIU/L)<sup>a</sup>
</td>
<td valign="top" align="left">TSH</td>
<td valign="top" align="char" char="&#xb1;">2.53 &#xb1; 1.03</td>
<td valign="top" align="char" char="&#xb1;">2.14 &#xb1; 1.31</td>
<td valign="top" align="center">0.480</td>
<td valign="top" align="char" char="&#xb1;">4.43 &#xb1; 7.71</td>
<td valign="top" align="char" char="&#xb1;">2.20 &#xb1; 1.57</td>
<td valign="top" align="center">0.362</td>
<td valign="top" align="char" char="&#xb1;">123.92 &#xb1; 181.05</td>
<td valign="top" align="char" char="&#xb1;">54.44 &#xb1; 84.77</td>
<td valign="top" align="center">0.30</td>
</tr>
<tr>
<td valign="top" align="left">FT4</td>
<td valign="top" align="char" char="&#xb1;">15.91 &#xb1; 3.02</td>
<td valign="top" align="char" char="&#xb1;">16.01 &#xb1; 2.27</td>
<td valign="top" align="center">0.861</td>
<td valign="top" align="char" char="&#xb1;">15.50 &#xb1; 1.90</td>
<td valign="top" align="char" char="&#xb1;">16.24 &#xb1; 2.60</td>
<td valign="top" align="center">0.390</td>
<td valign="top" align="char" char="&#xb1;">2.77 &#xb1; 1.94</td>
<td valign="top" align="char" char="&#xb1;">2.26 &#xb1; 1.36</td>
<td valign="top" align="center">0.328</td>
</tr>
<tr>
<td valign="top" align="left">FT3</td>
<td valign="top" align="char" char="&#xb1;">4.84 &#xb1; 0.84</td>
<td valign="top" align="char" char="&#xb1;">4.82 &#xb1; 0.61</td>
<td valign="top" align="center">0.936</td>
<td valign="top" align="char" char="&#xb1;">5.08 &#xb1; 1.47</td>
<td valign="top" align="char" char="&#xb1;">4.85 &#xb1; 0.74</td>
<td valign="top" align="center">0.504</td>
<td valign="top" align="char" char="&#xb1;">11.95 &#xb1; 2.08</td>
<td valign="top" align="char" char="&#xb1;">13.85 &#xb1; 2.06</td>
<td valign="top" align="center">0.01*</td>
</tr>
<tr>
<td valign="top" rowspan="4" align="left">T Stage</td>
<td valign="top" align="left">T<sub>1</sub>
</td>
<td valign="top" align="center">6 (21.43)</td>
<td valign="top" align="center">61 (53.16)</td>
<td valign="top" rowspan="3" align="center">&lt;0.001*</td>
<td valign="top" align="center">4 (33.33)</td>
<td valign="top" align="center">22 (64.71)</td>
<td valign="top" rowspan="3" align="center">0.014*</td>
<td valign="top" align="center">3 (23.08)</td>
<td valign="top" align="center">26 (78.78)</td>
<td valign="top" rowspan="3" align="center">&lt;0.001*</td>
</tr>
<tr>
<td valign="top" align="left">T<sub>2</sub>
</td>
<td valign="top" align="center">1 (3.57)</td>
<td valign="top" align="center">14 (1.27)</td>
<td valign="top" align="center">1 (8.33)</td>
<td valign="top" align="center">9 (26.47)</td>
<td valign="top" align="center">0(0.00)</td>
<td valign="top" align="center">5 (15.15)</td>
</tr>
<tr>
<td valign="top" align="left">T<sub>3</sub>
</td>
<td valign="top" align="center">15 (53.57)</td>
<td valign="top" align="center">4 (45.57)</td>
<td valign="top" align="center">5 (41.67)</td>
<td valign="top" align="center">3 (8.82)</td>
<td valign="top" align="center">5 (38.46)</td>
<td valign="top" align="center">2 (6.06)</td>
</tr>
<tr>
<td valign="top" align="left">T<sub>4</sub>
</td>
<td valign="top" align="center">6 (21.43)</td>
<td valign="top" align="center">0 (0.00)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">2 (16.67)</td>
<td valign="top" align="center">0 (0.00)</td>
<td valign="top" align="center"/>
<td valign="top" align="center">5 (38.46)</td>
<td valign="top" align="center">0 (0.00)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Primary site</td>
<td valign="top" align="left">Left/right lobe</td>
<td valign="top" align="center">28 (100.00)</td>
<td valign="top" align="center">77 (97.47)</td>
<td valign="top" rowspan="2" align="center">0.395</td>
<td valign="top" align="center">12 (100.00)</td>
<td valign="top" align="center">33 (97.06)</td>
<td valign="top" rowspan="2" align="center">0.548</td>
<td valign="top" align="center">13 (100.00)</td>
<td valign="top" align="center">32 (96.97)</td>
<td valign="top" rowspan="2" align="center">&gt;0.999</td>
</tr>
<tr>
<td valign="top" align="left">Isthmus</td>
<td valign="top" align="center">0 (0.00)</td>
<td valign="top" align="center">2 (2.53)</td>
<td valign="top" align="center">0 (0.00)</td>
<td valign="top" align="center">1 (2.94)</td>
<td valign="top" align="center">0 (0.00)</td>
<td valign="top" align="center">1 (3.03)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">Radiologists&#x2019; Interpretation</td>
<td valign="top" align="left">correct</td>
<td valign="top" align="center">21 (75.00)</td>
<td valign="top" align="center">64 (81.01)</td>
<td valign="top" rowspan="2" align="center">0.449</td>
<td valign="top" align="center">7 (58.33)</td>
<td valign="top" align="center">29 (85.29)</td>
<td valign="top" rowspan="2" align="center">0.052</td>
<td valign="top" align="center">10 (76.92)</td>
<td valign="top" align="center">23 (69.70)</td>
<td valign="top" rowspan="2" align="center">0.729</td>
</tr>
<tr>
<td valign="top" align="left">incorrect</td>
<td valign="top" align="center">7 (25.00)</td>
<td valign="top" align="center">15 (18.99)</td>
<td valign="top" align="center">5 (41.67)</td>
<td valign="top" align="center">5 (14.71)</td>
<td valign="top" align="center">3 (23.08)</td>
<td valign="top" align="center">10 (30.30)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">LN Status</td>
<td valign="top" align="left">positive</td>
<td valign="top" align="center">19 (67.86)</td>
<td valign="top" align="center">32 (40.51)</td>
<td valign="top" rowspan="2" align="center">0.013*</td>
<td valign="top" align="center">8(66.67)</td>
<td valign="top" align="center">10 (29.41)</td>
<td valign="top" rowspan="2" align="center">0.157</td>
<td valign="top" align="center">10 (76.92)</td>
<td valign="top" align="center">18 (54.55)</td>
<td valign="top" rowspan="2" align="center">0.197</td>
</tr>
<tr>
<td valign="top" align="left">negative</td>
<td valign="top" align="center">9 (32.14)</td>
<td valign="top" align="center">47 (59.49)</td>
<td valign="top" align="center">4 (33.33)</td>
<td valign="top" align="center">24 (70.59)</td>
<td valign="top" align="center">3 (23.08)</td>
<td valign="top" align="center">15(45.45)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The data are displayed as n (%) except otherwise noted.</p>
</fn>
<fn>
<p>
<sup>a</sup>Mean &#xb1; standard deviation.</p>
</fn>
<fn>
<p>ETE, Extrathyroidal Extension; M, Male; F, Female; TSH, Thyroid Stimulating Hormone; FT4, Free Thyroxine; FT3, Free Triiodothyronine; LN, lymph node.</p>
</fn>
<fn>
<p>*P &lt; 0.05</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s4_2">
<title>Radiomics Features and Prediction Performance of the Radiomics-Based Models</title>
<p>A total of 4227 radiomics features were extracted from each patient&#x2019;s images. The intra-observer and inter-observer ICCs were 0.867 and 0.915, respectively, indicating an excellent agreement on radiomics features. Four radiomics features (Small Area Low Gray Level Emphasis, Gray Level Variance, Difference Entropy, and Busyness) in the training set were finally selected (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>; <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Least absolute shrinkage and selection operator (LASSO) algorithm for radiomics features selection. <bold>(A)</bold> LASSO coefficient profiles of the 4 features. The y-axis represents coefficient of each feature. <bold>(B)</bold> Mean square error path.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-874396-g002.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>LASSO coefficient profiles of the 4 features.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Radiomics features</th>
<th valign="top" align="center">Phase</th>
<th valign="top" align="center">Feature type</th>
<th valign="top" align="center">Coefficient</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Small Area Low Gray Level Emphasis</td>
<td valign="top" align="left">Non-contrast</td>
<td valign="top" align="left">GLSZM</td>
<td valign="top" align="center">0.0426553</td>
</tr>
<tr>
<td valign="top" align="left">Gray Level Variance</td>
<td valign="top" align="left">Non-contrast</td>
<td valign="top" align="left">GLSZM</td>
<td valign="top" align="center">-0.023849</td>
</tr>
<tr>
<td valign="top" align="left">Difference Entropy</td>
<td valign="top" align="left">Non-contrast</td>
<td valign="top" align="left">GLSZM</td>
<td valign="top" align="center">0.014683</td>
</tr>
<tr>
<td valign="top" align="left">Busyness</td>
<td valign="top" align="left">Non-contrast</td>
<td valign="top" align="left">GLSZM</td>
<td valign="top" align="center">-0.007175</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>LASSO, least absolute shrinkage and selection operator; GLSZM, gray-level size zone matrix.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Predictive models built by using KNN, LR, DT, Linear-SVM, Gaussian-SVM, and Polynomial-SVM, showed favorable discriminatory abilities for radiomics parameters with AUCs of 0.841 (95% Confidence Interval [CI], 0.769-0.900), 0.774 (95% CI, 0.683-0.853), 0.841 (95% CI, 0.772-0.897), 0.774 (95% CI, 0.680-0.854), 0.805 (95% CI, 0.710-0.879), and 0.815 (0.708-0.888), respectively, in the training set (Figure 3 A). In the internal test set, the six radiomics models also showed good performance with AUCs of 0.669 (95% Confidence Interval [CI], 0.394-0.568), 0.701 (95% CI, 0.480-0.767), 0.680 (95% CI, 0.516-0.795), 0.694 (95% CI, 0.508-0.788), 0.642 (95% CI, 0.454-0.600), and 0.681 (0.466-0.700),  respectively (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Interestingly, in terms of AUC, the LR, which was later used to build the nomogram, demonstrated the best performance of the 6 models.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Receiver operating characteristic (ROC) curves of different models in training and test sets. Receiver operating characteristic (ROC) curves of K-Nearest Neighbor (KNN), Logistics Regression (LR), Decision Tree (DT), Linear-support vector machine (Linear-SVM), Gaussian-SVM, and Polynomial-SVM models in the training <bold>(A)</bold> and internal test <bold>(B)</bold> set. ROC curves of nomogram, radiomics signature, and radiologists&#x2019; interpretation in the training <bold>(C)</bold>, internal test <bold>(D)</bold>, external test <bold>(E)</bold> set. ROC curves of nomogram for division of minimal and gross extrathyroidal extension (ETE) in the internal test and external test set <bold>(F)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-874396-g003.tif"/>
</fig>
</sec>
<sec id="s4_3">
<title>Development and Validation of the Radiomics Nomogram</title>
<p>The 4 features mentioned above were selected and their coefficients were plugged into a formula for calculating Rad-score as described below:</p>
<disp-formula>
<mml:math display="block" id="M2">
<mml:mrow> <mml:mtext>Rad</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mtext>score</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mtext>Small&#xa0;Area&#xa0;Low&#xa0;Gray&#xa0;Level&#xa0;Emphasis</mml:mtext>
<mml:mo>&#x2217;</mml:mo>
<mml:mn>0.0426553682266122</mml:mn>
<mml:mo>+</mml:mo>
<mml:mtext>Gray&#xa0;Level&#xa0;Variance</mml:mtext>
<mml:mo>&#x2217;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.0238497391861649</mml:mn>
<mml:mo>+</mml:mo>
<mml:mtext>Difference&#xa0;Entropy</mml:mtext>
<mml:mo>&#x2217;</mml:mo>
<mml:mn>0.0146833132887633</mml:mn>
<mml:mo>+</mml:mo>
<mml:mtext>Busyness</mml:mtext>
<mml:mo>&#x2217;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>0.00717595762541243</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
<p>The ANOVA and multivariate logistic regression analysis only identified radiologists&#x2019; interpretation as being an independent ETE predictor (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). The values of Rad-score and radiologists&#x2019; interpretation for predicting the presence of ETE in PTC patients were quantified in our nomogram (score for each factor is shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). The radiomics nomogram showed a good prognostic capability, with AUCs of 0.860 (95% CI, 0.790-0.931), 0.750 (95% CI, 0.579-0.921), and 0.797 (95% CI, 0.665-0.926) in the training, internal test, and external test sets, respectively (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C&#x2013;E</bold>
</xref>; <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). Furthermore, the radiomics nomogram had a more powerful predictive efficiency than the interpretation of radiologists with 5 and 10 years of experience, whose AUC in the training, internal test, and external test sets were 0.762 (95% CI, 0.667-0.858), 0.718 (95% CI, 0.560-0.876), and 0.733 (95% CI, 0.615-0.841), respectively (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C&#x2013;E</bold>
</xref>). In the external test set, the nomogram&#x2019;s accuracy (0.848 vs. 0.717) and specificity (0.909 vs, 0.697) were higher than those of radiologist&#x2019;s interpretation, reflecting a better prognostic performance of the radiomics nomogram; however, the sensitivity of the nomogram (0.692, 95% CI 0.389-0.896) was similar with that of radiologists&#x2019; interpretation (0.769, 95% CI 0.460-0.938) (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). We tested this nomogram to distinguish minimal and grossly ETE in internal and external test set, and achieved relatively good performance with AUC of 0.800 (0.578-1.000) and 0.722(0.390-1.000), sensitivity of 0.800 (0.299-0.989) and 0.500(0.092-0.908), specificity of 0.667 (0.412-0.856) and 0.889(0.507-0.994), and accuracy of 0.696 (0.471-0.868) and 0.769(0.462-0.950) respectively. (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). The DCA showed that radiomics nomogram could add more benefit than treat patients as all-ETE or non-ETE when the threshold probability ranged from 0.10 to 0.50 in internal test set and 0.12 to 0.75 in the external test set (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>). The calibration curve for the radiomics nomogram, when assessed by the Hosmer-Lemeshow test, yielded <italic>P</italic> of 0.48, 0.88, and 0.34 in the training set, internal test set, and external test set, respectively (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5C, D</bold>
</xref>), demonstrated good agreement between actual status and ETE probabilities as predicted by the nomogram in all three sets.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>The selection of clinical risk factors for ETE by ANOVA and univariate LR analysis.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left">Variables</th>
<th valign="top" colspan="2" align="center">ANOVA</th>
<th valign="top" colspan="2" align="center">Univariate LR Analysis</th>
</tr>
<tr>
<th valign="top" align="center">F Value</th>
<th valign="top" align="center">P</th>
<th valign="top" align="center">OR</th>
<th valign="top" align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sex</td>
<td valign="top" align="center">2.642</td>
<td valign="top" align="center">0.107</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">0.752</td>
<td valign="top" align="center">0.388</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
</tr>
<tr>
<td valign="top" align="left">Primary Site</td>
<td valign="top" align="center">0.612</td>
<td valign="top" align="center">0.436</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
</tr>
<tr>
<td valign="top" align="left">Tumor Diameter</td>
<td valign="top" align="center">0.065</td>
<td valign="top" align="center">0.799</td>
<td valign="top" align="center">NA</td>
<td valign="top" align="center">NA</td>
</tr>
<tr>
<td valign="top" align="left">Radiologist&#x2019;s Interpretation</td>
<td valign="top" align="center">33.412</td>
<td valign="top" align="center">&lt;0.01*</td>
<td valign="top" align="center">1.506</td>
<td valign="top" align="center">&lt;0.01*</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ETE, extrathyroidal extension; ANOVA, analysis of variance; LR, logistic regression; OR, odds ratio; NA, not available.</p>
</fn>
<fn>
<p>*P &lt; 0.05</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Radiomics nomogram with radiomics signature (rad-score) and radiologists&#x2019; interpretation incorporated.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-874396-g004.tif"/>
</fig>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Efficacies of the models predicting ETE in patients with PTC.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">AUC</th>
<th valign="top" align="center">Sensitivity</th>
<th valign="top" align="center">Specificity</th>
<th valign="top" align="center">Accuracy</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="5" align="left">
<bold>Training Set</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">Rad-score</td>
<td valign="top" align="center">0.774 (0.677-0.871)</td>
<td valign="top" align="center">0.722 (0.671-0.861)</td>
<td valign="top" align="center">0.750 (0.571-0.893)</td>
<td valign="top" align="center">0.757 (0.665-0.835)</td>
</tr>
<tr>
<td valign="top" align="left">Radiologists&#x2019; interpretation</td>
<td valign="top" align="center">0.762 (0.667-0.858)</td>
<td valign="top" align="center">0.810 (0.712-0.886)</td>
<td valign="top" align="center">0.714 (0.536-0.857)</td>
<td valign="top" align="center">0.785 (0.695-0.859)</td>
</tr>
<tr>
<td valign="top" align="left">Nomogram</td>
<td valign="top" align="center">0.860 (0.790-0.931)</td>
<td valign="top" align="center">0.734 (0.633-0.853)</td>
<td valign="top" align="center">0.786 (0.643-0.929)</td>
<td valign="top" align="center">0.710 (0.615-0.794)</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left">
<bold>Internal Test Set</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">Rad-score</td>
<td valign="top" align="center">0.701 (0.545-0.857)</td>
<td valign="top" align="center">0.706 (0.588-0.882)</td>
<td valign="top" align="center">0.583 (0.333-0.833)</td>
<td valign="top" align="center">0.674 (0.520-0.805)</td>
</tr>
<tr>
<td valign="top" align="left">Radiologists&#x2019; interpretation</td>
<td valign="top" align="center">0.718 (0.560-0.876)</td>
<td valign="top" align="center">0.853 (0.706-0.971)</td>
<td valign="top" align="center">0.583 (0.333-0.833)</td>
<td valign="top" align="center">0.783 (0.636-0.891)</td>
</tr>
<tr>
<td valign="top" align="left">Nomogram</td>
<td valign="top" align="center">0.750 (0.579-0.921)</td>
<td valign="top" align="center">0.765 (0.584-0.886)</td>
<td valign="top" align="center">0.583 (0.333-0.833)</td>
<td valign="top" align="center">0.717 (0.565-0.840)</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left">
<bold>External Test Set</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">Rad-score</td>
<td valign="top" align="center">0.606 (0.469-0.748)</td>
<td valign="top" align="center">0.692 (0.389-0.896)</td>
<td valign="top" align="center">0.485 (0.312-0.661)</td>
<td valign="top" align="center">0.543 (0.390-0.691)</td>
</tr>
<tr>
<td valign="top" align="left">Radiologists&#x2019; interpretation</td>
<td valign="top" align="center">0.733 (0.615-0.841)</td>
<td valign="top" align="center">0.769 (0.460-0.938)</td>
<td valign="top" align="center">0.697 (0.511-0.838)</td>
<td valign="top" align="center">0.717 (0.565-0.840)</td>
</tr>
<tr>
<td valign="top" align="left">Nomogram</td>
<td valign="top" align="center">0.797 (0.665-0.926)</td>
<td valign="top" align="center">0.692 (0.389-0.896)</td>
<td valign="top" align="center">0.909 (0.745-0.976)</td>
<td valign="top" align="center">0.848 (0.711-0.937)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ETE, extrathyroidal extension; PTC, Papillary thyroid cancer; Rad-score, radiomics signature score; AUC, area under curves.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>
<bold>(A, B)</bold> Decision curve analysis (DCA) for the prediction models in the internal and external test set. The y-axis represents the net benefits, while the x-axis represents the threshold probability. The blue line represents the radiomics nomogram. The red line represents the radiologists&#x2019; interpretation model. The gray line represents the assumption that no patients were diagnosed as ETE. The horizontal black line represents the assumption that all patients were diagnosed as ETE. Calibration curves of radiomics nomogram in the training <bold>(C)</bold>, internal test <bold>(C)</bold>, and external test <bold>(D)</bold> sets. The diagonal line represents the perfect prediction of the radiomics nomogram.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-874396-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s5" sec-type="discussion">
<title>Discussion</title>
<p>Most patients with PTC have a favorable long-term survival prognosis (<xref ref-type="bibr" rid="B18">18</xref>); however, ETE remains an independent risk factor affecting overall survival and clinical decision making (<xref ref-type="bibr" rid="B19">19</xref>). Therefore, it is crucial to create a powerful predictive tool that can help surgeons and inexperienced radiologists evaluate possible ETE and make a clinical decision regarding treatment. In this retrospective multicenter study, six predictive models were established for verifying that radiomics could be used to predict ETE. Furthermore, a nomogram was constructed based on radiomics information and clinical risk factors, and displayed an excellent ability to predict ETE, with AUCs of 0.750 and 0.797 in an internal test set and external test set, respectively. Those results indicated that the radiomics nomogram could serve as an independent medical decision-making tool, and satisfy the requirements of precision medicine.</p>
<p>Unlike previous studies (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>), the present study investigated the value of radiomics with six classifiers. This result showed that radiomics could play a crucial role in ETE prediction. Nomograms based on radiomics have been widely used to predict medical prognoses (<xref ref-type="bibr" rid="B25">25</xref>) and clinical outcomes by combining a Rad-score and clinical risk factors (<xref ref-type="bibr" rid="B26">26</xref>). The nomogram constructed in this study demonstrated an ability to generate individualized predictions that were useful for identifying and stratifying patients with PTC.</p>
<p>Some previous studies have been conducted on this topic (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Bin Chen et&#xa0;al. (<xref ref-type="bibr" rid="B27">27</xref>) and Xian Wang et&#xa0;al. (<xref ref-type="bibr" rid="B28">28</xref>) constructed radiomics nomograms for ETE prediction based on CT images and US images, respectively. Nevertheless, their studies lacked an external test set. Furthermore, those investigators only used a single classifier (logistic regression analysis) to evaluate the radiomics approach and build a nomogram. Their results showed that the nomogram had a discrimination ability (AUCs of 0.772 and 0.824, respectively, in an internal test set) for ETE classification that was similar to that of our nomogram (AUC = 0.750 in internal test set). When comparing the two nomograms, the nomogram developed in our multicenter study has notable advantages. First, the use of an external test set improved the reliability of our radiomics nomogram and proved that it had relatively good repeatability and generalization ability. This is the first study to use a CT radiomics nomogram adding to time sequential features which greatly enhanced a variety of features to predict ETE. However, no single feature was proven to be statistically significant, which means the time change of CT images may play a minor role in ETE prediction. Finally, the ability of this radiomics nomogram to predict ETE approximated that of experienced radiologists&#x2019; interpretation, showing that the nomogram could be used to help surgeons make clinical decisions prior to performing surgery, and satisfy the requirements of precision medicine.</p>
<p>In addition, 4 selected features were all from non-contrast CT images, suggesting that there was no obvious advantage of features extracted from CE-CT images in ETE diagnosis. However, CE-CT is useful in ETE interpretation.</p>
<p>The limitations of this study are as follows: (1) PTCs with a diameter &lt; 1&#xa0;cm were included in the study, and may have been difficult to distinguish on CT images; this may have led to sample bias. To address this problem, any doubt was resolved by discussion or consultation with a third radiologist who had 20 years of experience. (2) The study&#x2019;s retrospective design may have led to selection bias. Prospective studies are needed to control for confounding variables. (3) A manual segmentation approach is time-consuming and may affect the precision of feature extraction in some cases; however, the ICCs for intra- and inter-observer agreement ranged from 0.809 to 0.923. Previous studies showed that the automatic segmentation method may facilitate the use of radiomics in busy clinical practice and lead to high degrees of intra- and inter-observer reproducibility (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>). A further study will use automatic segmentation to draw the ROIs. (4) CE-CT leads to higher total radiation doses, longer examination times, and use of contrast medium, limiting its broad use in clinical practice. (5) Only the machine learning method was used, and previous studies have shown that deep learning methods have a certain value for predicting lymph node metastases and classifying PTC (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>); however, no study has ever constructed an ETE-prediction model by using deep learning methods. In light of this, we will focus on that in a subsequent study.</p>
</sec>
<sec id="s6">
<title>Conclusion</title>
<p>In this study, a non-invasive nomogram combined the Rad-score and radiologists&#x2019; interpretation showing good repeatability and generalization ability for predicting ETE. This radiomics nomogram may also facilitate clinical decision-making; however, additional studies with larger sample sizes and more centers should be performed to improve the nomogram&#x2019;s efficiency.</p>
</sec>
<sec id="s7" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s8" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Institutional Review Board of The Affiliated Yantai Yuhuangding Hospital of Qingdao University. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s9" sec-type="author-contributions">
<title>Author Contributions</title>
<p>PY, XW, and JL implemented the literature searching and manuscript writing. KC, QW, and NM implemented the ETE interpretation. GL implemented ROI segmentation. HZ contributed to data analysis, figure making, and algorithm development. YM, GZ, XH, and LD identified the radiological characteristics of PTC and estimated and adjusted the accuracy of ROIs. XS, YM, and NM conducted the design, quality control, and data interpretation of this study. All authors analyzed the data and their significance and were involved in the final editing and approval of the submitted article. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s10" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Taishan Scholars Project (No. ts20190991).</p>
</sec>
<sec id="s11" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>Authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank professor Dexin Yu of Qilu Hospital of Shandong University provided CT images and clinical information of external test set in this study.</p>
</ack>
<sec id="s13" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2022.874396/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2022.874396/full#supplementary-material</ext-link>
</p>
  <supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<sec id="s14">
<title>Abbreviations</title>
<p>AJCC, American Joint Committee on Cancer; ANOVA, analysis of variance; AUC, area under the curve; CE-CT, contrast-Enhanced computed tomography; CI, confidence interval; CT, Computed Tomography; DCA, decision curve analysis; DT, decision Tree; ETE, extrathyroidal extension; ICCs, intra- and inter-class correlation coefficients; KNN, k-nearest neighbor; LASSO, least absolute shrinkage and selection operator; LR, logistic regression; MRI, magnetic resonance imaging; PTC, papillary thyroid cancer; ROC, Receiver Operating Characteristic; SVM, support vector machine; US, Ultrasound; VIF, variance inflation factor; VOI, volume of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bray</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ferlay</surname> <given-names>J</given-names>
</name>
<name>
<surname>Soerjomataram</surname> <given-names>I</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Torre</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Jemal</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries</article-title>. <source>CA Cancer J Clin</source> (<year>2018</year>) <volume>68</volume>(<issue>6</issue>):<fpage>394</fpage>&#x2013;<lpage>424</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="web">
<source>Cancer Stat Facts: Thyroid Cancer</source> (<year>2020</year>). Available at: <uri xlink:href="https://seer.cancer.gov/statfacts/html/thyro.html">https://seer.cancer.gov/statfacts/html/thyro.html</uri>.</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seib</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Sosa</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Evolving Understanding of the Epidemiology of Thyroid Cancer</article-title>. <source>Endocrinol Metab Clin North Am</source> (<year>2019</year>) <volume>48</volume>(<issue>1</issue>):<fpage>23</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ecl.2018.10.002</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amin</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Edge</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Greene</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Byrd</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Brookland</surname> <given-names>Rk</given-names>
</name>
<name>
<surname>Washington</surname> <given-names>MK</given-names>
</name>
<etal/>
</person-group>. <article-title>AJCC Cancer Staging Manual. Chicago: American College of Surgeons press</article-title> (<year>2017</year>).</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HI</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SW</given-names>
</name>
<etal/>
</person-group>. <article-title>Prognostic Significance of Gross Extrathyroidal Extension Invading Only Strap Muscles in Differentiated Thyroid Carcinoma</article-title>. <source>Br J Surg</source> (<year>2018</year>) <volume>105</volume>(<issue>9</issue>):<page-range>1155&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bjs.10830</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sapuppo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tavarelli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Malandrino</surname> <given-names>P</given-names>
</name>
<name>
<surname>Belfiore</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vigneri</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Lymph Node Location Is a Risk Factor for Papillary Thyroid Cancer-Related Death</article-title>. <source>J Endocrinol Invest</source> (<year>2018</year>) <volume>41</volume>(<issue>11</issue>):<page-range>1349&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40618-018-0865-5</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>KW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Predictive Factors for Extrathyroidal Extension of Papillary Thyroid Carcinoma Based on Preoperative Sonography</article-title>. <source>J Ultras Med</source> (<year>2014</year>) <volume>33</volume>(<issue>2</issue>):<page-range>231&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7863/ultra.33.2.231</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gweon</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Son</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Youk</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Park</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Preoperative Assessment of Extrathyroidal Extension of Papillary Thyroid Carcinoma: Comparison of 2- and 3-Dimensional Sonography</article-title>. <source>J Ultras Med</source> (<year>2014</year>) <volume>33</volume>(<issue>5</issue>):<page-range>819&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7863/ultra.33.5.819</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Son</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Youk</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Park</surname> <given-names>CS</given-names>
</name>
<etal/>
</person-group>. <article-title>Preoperative Prediction of the Extrathyroidal Extension of Papillary Thyroid Carcinoma With Ultrasonography Versus Mri: A Retrospective Cohort Study</article-title>. <source>Int J Surg</source> (<year>2014</year>) <volume>12</volume>(<issue>5</issue>):<page-range>544&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijsu.2014.03.003</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Cha</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Yun</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>CS</given-names>
</name>
<etal/>
</person-group>. <article-title>Locally Advanced Thyroid Cancer: Can Ct Help in Prediction of Extrathyroidal Invasion to Adjacent Structures</article-title>? <source>AJR Am J Roentgenol</source> (<year>2010</year>) <volume>195</volume>(<issue>3</issue>):<page-range>W240&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2214/ajr.09.3965</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillies</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Kinahan</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Hricak</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Radiomics: Images Are More Than Pictures, They Are Data</article-title>. <source>Radiology</source> (<year>2016</year>) <volume>278</volume>(<issue>2</issue>):<page-range>563&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/radiol.2015151169</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname> <given-names>WL</given-names>
</name>
<name>
<surname>Hosny</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schabath</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Giger</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Birkbak</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Mehrtash</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Artificial Intelligence in Cancer Imaging: Clinical Challenges and Applications</article-title>. <source>CA Cancer J Clin</source> (<year>2019</year>) <volume>69</volume>(<issue>2</issue>):<page-range>127&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21552</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geras</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Mann</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Moy</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives</article-title>. <source>Radiology</source> (<year>2019</year>) <volume>293</volume>(<issue>2</issue>):<page-range>246&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/radiol.2019182627</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gisev</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>TF</given-names>
</name>
</person-group>. <article-title>Interrater Agreement and Interrater Reliability: Key Concepts, Approaches, and Applications</article-title>. <source>Res Soc Adm Pharm</source> (<year>2013</year>) <volume>9</volume>(<issue>3</issue>):<page-range>330&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.sapharm.2012.04.004</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beurnier</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jutant</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Jevnikar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Boucly</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pichon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Preda</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Characteristics and Outcomes of Asthmatic Patients With Covid-19 Pneumonia Who Require Hospitalisation</article-title>. <source>Eur Respir J</source> (<year>2020</year>) <volume>56</volume>(<issue>5</issue>):<fpage>2001875</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1183/13993003.01875-2020</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zwanenburg</surname> <given-names>A</given-names>
</name>
<name>
<surname>Valli&#xe8;res</surname> <given-names>M</given-names>
</name>
<name>
<surname>Abdalah</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Aerts</surname> <given-names>H</given-names>
</name>
<name>
<surname>Andrearczyk</surname> <given-names>V</given-names>
</name>
<name>
<surname>Apte</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-Based Phenotyping</article-title>. <source>Radiology</source> (<year>2020</year>) <volume>295</volume>(<issue>2</issue>):<page-range>328&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/radiol.2020191145</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauerbrei</surname> <given-names>W</given-names>
</name>
<name>
<surname>Royston</surname> <given-names>P</given-names>
</name>
<name>
<surname>Binder</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Selection of Important Variables and Determination of Functional Form for Continuous Predictors in Multivariable Model Building</article-title>. <source>Stat Med</source> (<year>2007</year>) <volume>26</volume>(<issue>30</issue>):<page-range>5512&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/sim.3148</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roman</surname> <given-names>BR</given-names>
</name>
<name>
<surname>Morris</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>The Thyroid Cancer Epidemic, 2017 Perspective</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source> (<year>2017</year>) <volume>24</volume>(<issue>5</issue>):<page-range>332&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/med.0000000000000359</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perrier</surname> <given-names>ND</given-names>
</name>
<name>
<surname>Brierley</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Tuttle</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Differentiated and Anaplastic Thyroid Carcinoma: Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual</article-title>. <source>CA Cancer J Clin</source> (<year>2018</year>) <volume>68</volume>(<issue>1</issue>):<fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21439</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limkin</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>R</given-names>
</name>
<name>
<surname>Dercle</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zacharaki</surname> <given-names>EI</given-names>
</name>
<name>
<surname>Robert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Reuz&#xe9;</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Promises and Challenges for the Implementation of Computational Medical Imaging (Radiomics) in Oncology</article-title>. <source>Ann Oncol</source> (<year>2017</year>) <volume>28</volume>(<issue>6</issue>):<page-range>1191&#x2013;206</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/annonc/mdx034</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambin</surname> <given-names>P</given-names>
</name>
<name>
<surname>Leijenaar</surname> <given-names>RTH</given-names>
</name>
<name>
<surname>Deist</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Peerlings</surname> <given-names>J</given-names>
</name>
<name>
<surname>de Jong</surname> <given-names>EEC</given-names>
</name>
<name>
<surname>van Timmeren</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Radiomics: The Bridge Between Medical Imaging and Personalized Medicine</article-title>. <source>Nat Rev Clin Oncol</source> (<year>2017</year>) <volume>14</volume>(<issue>12</issue>):<page-range>749&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrclinonc.2017.141</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>XJ</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>CP</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>GZ</given-names>
</name>
<etal/>
</person-group>. <article-title>A Ct-Based Radiomics Nomogram for Differentiation of Lympho-Associated Benign and Malignant Lesions of the Parotid Gland</article-title>. <source>Eur Radiol</source> (<year>2021</year>) <volume>31</volume>(<issue>5</issue>):<page-range>2886&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00330-020-07421-4</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Development of a Radiomics Nomogram Based on the 2d and 3d Ct Features to Predict the Survival of Non-Small Cell Lung Cancer Patients</article-title>. <source>Eur Radiol</source> (<year>2019</year>) <volume>29</volume>(<issue>5</issue>):<page-range>2196&#x2013;206</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00330-018-5770-y</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Preoperative Radiomics Nomogram for Microvascular Invasion Prediction in Hepatocellular Carcinoma Using Contrast-Enhanced Ct</article-title>. <source>Eur Radiol</source> (<year>2019</year>) <volume>29</volume>(<issue>7</issue>):<page-range>3595&#x2013;605</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00330-018-5985-y</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname> <given-names>GW</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>YD</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>FP</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>YX</given-names>
</name>
<etal/>
</person-group>. <article-title>Biliary Tract Cancer at Ct: A Radiomics-Based Model to Predict Lymph Node Metastasis and Survival Outcomes</article-title>. <source>Radiology</source> (<year>2019</year>) <volume>290</volume>(<issue>1</issue>):<page-range>90&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1148/radiol.2018181408</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iasonos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schrag</surname> <given-names>D</given-names>
</name>
<name>
<surname>Raj</surname> <given-names>GV</given-names>
</name>
<name>
<surname>Panageas</surname> <given-names>KS</given-names>
</name>
</person-group>. <article-title>How to Build and Interpret a Nomogram for Cancer Prognosis</article-title>. <source>J Clin Oncol</source> (<year>2008</year>) <volume>26</volume>(<issue>8</issue>):<page-range>1364&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1200/jco.2007.12.9791</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Computed Tomography Radiomic Nomogram for Preoperative Prediction of Extrathyroidal Extension in Papillary Thyroid Carcinoma</article-title>. <source>Front Oncol</source> (<year>2019</year>) <volume>9</volume>:<elocation-id>829</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2019.00829</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Agyekum</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma</article-title>. <source>Front Oncol</source> (<year>2021</year>) <volume>11</volume>:<elocation-id>625646</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2021.625646</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Men</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Cnn-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy</article-title>. <source>Front Oncol</source> (<year>2020</year>) <volume>10</volume>:<elocation-id>524</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2020.00524</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masood</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>B</given-names>
</name>
<name>
<surname>Mathavan</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Automatic Choroid Layer Segmentation From Optical Coherence Tomography Images Using Deep Learning</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>3058</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-39795-x</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gardner</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Elshaikh</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Siddiqui</surname> <given-names>F</given-names>
</name>
<name>
<surname>Movsas</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Automatic Segmentation of the Prostate on Ct Images Using Deep Neural Networks (Dnn)</article-title>. <source>Int J Radiat Oncol Biol Phys</source> (<year>2019</year>) <volume>104</volume>(<issue>4</issue>):<page-range>924&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijrobp.2019.03.017</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghavami</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gibson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bonmati</surname> <given-names>E</given-names>
</name>
<name>
<surname>Emberton</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>CM</given-names>
</name>
<etal/>
</person-group>. <article-title>Automatic Segmentation of Prostate Mri Using Convolutional Neural Networks: Investigating the Impact of Network Architecture on the Accuracy of Volume Measurement and Mri-Ultrasound Registration</article-title>. <source>Med Imag Anal</source> (<year>2019</year>) <volume>58</volume>:<elocation-id>101558</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.media.2019.101558</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>YC</given-names>
</name>
<name>
<surname>AlZoubi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jassim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>YB</given-names>
</name>
<etal/>
</person-group>. <article-title>A Generic Deep Learning Framework to Classify Thyroid and Breast Lesions in Ultrasound Images</article-title>. <source>Ultrasonics</source> (<year>2021</year>) <volume>110</volume>:<elocation-id>106300</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ultras.2020.106300</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ha</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Application of Deep Learning to the Diagnosis of Cervical Lymph Node Metastasis From Thyroid Cancer With Ct</article-title>. <source>Eur Radiol</source> (<year>2019</year>) <volume>29</volume>(<issue>10</issue>):<page-range>5452&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00330-019-06098-8</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>